Clinical Study

Hypertension Control and Cardiometabolic Risk: A Regional Perspective

Table 6

Blood pressure and LDL-Cholesterol (mmol/L ± SD, adjusted for age, gender, and diabetes).

Total
( ,529)
Northern Europe
( )
Southern Europe
( )
North America
( )
Middle East
( )
Asia
( )
value

SBP (mmHg)
 <1202.9 (0.044)3.0 (0.088)3.0 (0.076)2.5 (0.109)2.8 (0.231)2.8 (0.093)0.0003
 120–1393.0 (0.048)3.1 (0.035)3.0 (0.028)2.4 (0.054)2.9 (0.121)2.9 (0.042)<0.0001
 140–1593.2 (0.015)3.2 (0.025)3.2 (0.024)2.6 (0.053)3.4 (0.075)3.0 (0.038)<0.0001
 160–1793.3 (0.020)3.3 (0.033)3.3 (0.032)2.7 (0.081)3.5 (0.080)3.3 (0.057)<0.0001
 ≥1803.4 (0.034)3.4 (0.055)3.5 (0.058)3.0 (0.153)3.9 (0.131)3.5 (0.096)<0.0001
value<0.0001<0.0001<0.0001<0.00010.0005<0.0001
DBP (mmHg)
 <903.0 (0.013)3.1 (0.022)3.1 (0.021)2.4 (0.037)3.0 (0.081)2.9 (0.031)<0.0001
 90–993.3 (0.016)3.3 (0.028)3.3 (0.027)2.8 (0.074)3.4 (0.073)3.1 (0.045)<0.0001
 100–1093.4 (0.026)3.4 (0.047)3.4 (0.041)2.9 (0.141)3.9 (0.098)3.4 (0.069)<0.0001
 ≥1103.5 (0.049)3.5 (0.086)3.6 (0.080)3.9 (0.311)3.5 (0.169)3.6 (0.151)0.5736
value<0.0001<0.0001<0.0001<0.0001<0.0001<0.0001
RR (mmHg)
 uncontrolled*3.4 (0.014)3.3 (0.019)3.3 (0.018)2.7 (0.042)3.5 (0.050)3.1 (0.029)<0.0001
 controlled**3.0 (0.012)3.0 (0.034)3.0 (0.027)2.4 (0.050)2.9 (0.115)2.9 (0.040)<0.0001
value<0.0001<0.0001<0.0001<0.0001<0.0001<0.0001

*SBP/DBP ≥140/90 in non-diabetic and ≥130/80 in diabetic patients, **<140/90 in non-diabetic and <130/80 in diabetic patients.